Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
SAB Biotherapeutics Unveils New Data From COVID-19 Programs Reinforcing Efficacy Against Variants
September 28, 2022
Tickers
SABS
From Benzinga
Ocugen Inks US Development Pact For Its Intranasal COVID-19 Vaccine
September 28, 2022
Tickers
OCGN
From Benzinga
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
September 27, 2022
From Benzinga
As Moderna Grapples With Supply Shortage, FDA Gives Nod To Additional Lots of COVID-19 Booster
September 27, 2022
From Benzinga
Valneva Tries Reviving COVID-19 Vaccine Play As It Talks With Potential Partner For An Updated Shot
September 26, 2022
Tickers
VALN
From Benzinga
Pfizer CEO Contracts COVID-19 Infection For Second Time
September 26, 2022
From Benzinga
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Kids, But Scrambles Supply Challenges
September 26, 2022
From Benzinga
Switzerland To Dispose 10M Expired COVID-19 Vaccine Doses From Moderna
September 26, 2022
From Benzinga
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
September 23, 2022
From Benzinga
Pfizer To Supply 6M COVID-19 Therapy Courses To Low Income Countries
September 22, 2022
Tickers
PFE
From Benzinga
AstraZeneca's COVID-19 Antibody Treatment Scores Approval In Europe
September 20, 2022
From Benzinga
Moderna Provides Vaccine For Preclinical Studies As WHO Tries Developing Its Own COVID-19 Shot: Report
September 19, 2022
From Benzinga
Valneva Cuts Ties With Its COVID-19 Vaccine Manufacturing Partner In Germany
September 19, 2022
Tickers
VALN
From Benzinga
AstraZeneca's COVID-19 Antibody Cocktail, RSV Treatment For Infants Gets European Authority Backing
September 16, 2022
From Benzinga
Omeros COVID-19 Treatment Reduced Mortality Risk, But Biased Data Rendered Analysis Meaningless
September 15, 2022
Tickers
OMER
From Benzinga
COVID-19 Vaccine Supply To China? Moderna CEO Says Capacity Available
September 14, 2022
Tickers
MRNA
From Benzinga
Atea Pharmaceuticals To Advance Global Late-Stage COVID-19 Study of Bemnifosbuvir
September 13, 2022
Tickers
AVIR
From Benzinga
US Judge Dismisses Shareholder Lawsuit Over AstraZeneca's COVID-19 Vaccine Disclosures: Report
September 13, 2022
From Benzinga
Europe Approves Novavax's COVID-19 Vaccine Booster For Adults
September 12, 2022
Tickers
NVAX
From Benzinga
FDA Schedules Adcomm For Veru's Cancer Drug Repurposed For COVID-19
September 08, 2022
Tickers
VERU
From Benzinga
Biophytis Shares Surge After Promising Data From COVID-19 Treatment Study
September 07, 2022
Tickers
BPTS
From Benzinga
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
September 06, 2022
From Benzinga
FDA Might Need New Data From Eiger Bio's COVID-19 Treatment Prospect
September 06, 2022
Tickers
EIGR
From Benzinga
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
September 02, 2022
From Benzinga
Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines
September 01, 2022
From Benzinga
AstraZeneca Scores Its First Global Approval For Antibody Evusheld As COVID-19 Treatment
August 30, 2022
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
